Skip to main content
$143.96 $2.11 (1.5%)

04:30 PM EDT on 09/22/20

Repligen Corp (NASDAQ:RGEN)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Current Price $143.96 Mkt Cap $7.4B
Open $141.78 P/E Ratio 241.43
Prev. Close $143.96 Div. (Yield) $0.00 (0.0%)
Daily Range $139.74 - $144.24 Volume 102,932
52-Wk Range $72.32 - $159.97 Avg. Daily Vol. 406,786

Caps

How do you think NASDAQ:RGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

531 Outperform
13 Underperform
 

All-Star Players

145 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

XMFBlacknGoldX (95.51)
Submitted April 11, 2016

I uncovered Repligen in 2013 when it was trading at a lowly $10 per share. At that time few had realized it was no longer developing drug candidates (risky, expensive, time-consuming -- apparently the TMF description for the company has yet to… More

Skyshadow664 (< 20)
Submitted June 14, 2012

These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More

NASDAQ:RGEN VS S&P 500 (SPY)

Fools bullish on NASDAQ:RGEN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about RGEN.

Recs

0
Member Avatar JJMarshall (66.39) Submitted: 9/3/2020 2:45:42 PM : Outperform Start Price: $151.33 NASDAQ:RGEN Score: -0.69

I like the whole making the tools for a growing industry, an industry that has been growing for awhile.

Recs

0
Member Avatar Brainsliver (80.77) Submitted: 9/3/2020 1:42:36 PM : Outperform Start Price: $151.33 NASDAQ:RGEN Score: -0.69

Picks-and-shovels play in Pharma. Manufactures the machines that enables production of current standard for advanced drugs.

Recs

0
Member Avatar SethLopez (83.43) Submitted: 9/2/2020 3:35:35 PM : Outperform Start Price: $155.23 NASDAQ:RGEN Score: +0.16

winners win.

Leaderboard

Find the members with the highest scoring picks in RGEN.

Score Leader

Stevegoldenfool

Stevegoldenfool (< 20) Score: +4,172.05

The Score Leader is the player with the highest score across all their picks in RGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Stevegoldenfool < 20 9/26/2011 Outperform 5Y $3.22 +4,360.25% +188.19% +4,172.05 0 Comment
TXawlman 95.91 10/26/2006 Outperform 5Y $3.37 +4,162.99% +153.22% +4,009.76 1 Comment
toroandbruin 63.93 10/25/2006 Outperform 1Y $3.37 +4,161.72% +153.52% +4,008.20 0 Comment
sincroton < 20 8/25/2006 Outperform 1Y $3.36 +4,174.40% +171.75% +4,002.66 1 Comment
warbucks52 < 20 8/25/2006 Outperform 1Y $3.36 +4,174.40% +171.88% +4,002.53 0 Comment
runic42 90.94 10/2/2006 Outperform 1Y $3.40 +4,124.12% +162.58% +3,961.53 0 Comment
Vanter1 99.01 11/11/2011 Outperform 5Y $3.41 +4,111.73% +160.59% +3,951.14 0 Comment
marky985 < 20 10/27/2008 Outperform 3Y $3.32 +4,225.90% +291.79% +3,934.12 0 Comment
youmustwhipit < 20 10/27/2008 Outperform NS $3.32 +4,225.90% +291.79% +3,934.12 0 Comment
wonderpiks 64.27 5/6/2010 Outperform 5Y $3.42 +4,099.42% +184.10% +3,915.31 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RGEN.